Global Device Company to Build R&D Center in Pearland, TX
10/12/2011
Headquartered in South Jordan, Utah, Merit develops, manufactures and distributes proprietary disposable medical devices used in interventional and diagnostic procedures (i.e., cardiology, radiology and endoscopy). It serves hospitals worldwide, and employs about 2,300 associates.
The company conducted a multi-state site search before choosing Pearland for its new project. "We wanted to be part of a community that was growing," said Greg Fredde, Merit's VP of government affairs. "This is a location that provides Merit employees easy access to the facility with minimal disruptions. Pearland's investments, infrastructure and retail amenities will also be beneficial to employees."
Pearland Mayor Tom Reid said Merit is the second medical manufacturing facility to choose to locate in Pearland, and follows on the heels of Cardiovascular Systems, Inc. "It has been a long-standing goal of the City to cultivate a broad spectrum of medical-related organizations in our community. Merit's selection of Pearland is a testament to our efforts and willingness to work with businesses interested in investing in our city."
Project Announcements
Little Leaf Farms Plans Coffee County, Tennessee, Production Operations
07/02/2025
White Rock Truss & Components Expands Lee County, Virginia, Operations
07/02/2025
Fox Tank Company Plans Coshocton, Ohio, Operations
07/02/2025
Ascentek Expands Shreveport, Louisiana, Operations
07/02/2025
ProBio Establishes Hopewell, New Jersey, Gene Therapy Operations
07/02/2025
22nd Century Technologies Expands Fairfax County, Virginia, Headquarters Operations
07/02/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
From Silicon to Server: Mapping the Data Center Supply Chain
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
First Person: David Robey, Co-CEO of QTS Data Centers
Q2 2025